Policy Incentives Drive the Thriving Innovation and R&D of Traditional Chinese Medicine

Release time：

2025-03-01

The state has introduced a series of policies and measures to encourage innovation and R&D in traditional Chinese medicine, injecting strong momentum into the development of the TCM industry.

 　　The state has introduced a series of policies and measures to encourage innovation and R&D in traditional Chinese medicine, injecting strong momentum into the industry’s development. These policies cover multiple areas, including increased funding for scientific research, streamlined approval procedures, and incentives for industry–university–research collaboration. With this policy support, numerous TCM enterprises have stepped up their R&D investments and partnered with research institutions to develop new TCM drugs. Recently, several innovative TCM drugs with independent intellectual property rights have been approved for clinical trials, demonstrating unique advantages in the treatment of chronic and complex diseases. The robust growth of TCM innovation and R&D not only helps to preserve and promote the culture of TCM but also provides the global pharmaceutical market with more safe and effective therapeutic options. 